HomeCompareEMHTF vs DIVO

EMHTF vs DIVO: Dividend Comparison 2026

EMHTF yields 4938.27% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMHTF wins by $55146348937607.21M in total portfolio value
10 years
EMHTF
EMHTF
● Live price
4938.27%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55146348937607.24M
Annual income
$53,033,758,961,414,200,000.00
Full EMHTF calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — EMHTF vs DIVO

📍 EMHTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMHTFDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMHTF + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMHTF pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMHTF
Annual income on $10K today (after 15% tax)
$419,753.09/yr
After 10yr DRIP, annual income (after tax)
$45,078,695,117,202,070,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, EMHTF beats the other by $45,078,695,117,202,070,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMHTF + DIVO for your $10,000?

EMHTF: 50%DIVO: 50%
100% DIVO50/50100% EMHTF
Portfolio after 10yr
$27573174468803.64M
Annual income
$26,516,879,480,707,100,000.00/yr
Blended yield
96.17%
📊

Analyst Conviction Gap

Where Wall Street is split right now

EMHTF
Analyst Ratings
1
Hold
Consensus: Hold
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMHTF buys
0
DIVO buys
0
No recent congressional trades found for EMHTF or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMHTFDIVO
Forward yield4938.27%6.62%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$55146348937607.24M$31.0K
Annual income after 10y$53,033,758,961,414,200,000.00$1,008.47
Total dividends collected$55003355952995.54M$8.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: EMHTF vs DIVO ($10,000, DRIP)

YearEMHTF PortfolioEMHTF Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$504,527$493,827.16$11,362$661.96+$493.2KEMHTF
2$23,824,817$23,284,973.37$12,860$702.91+$23.81MEMHTF
3$1,053,123,085$1,027,630,530.32$14,504$743.56+$1053.11MEMHTF
4$43,579,292,978$42,452,451,277.21$16,303$783.73+$43579.28MEMHTF
5$1,688,429,051,261$1,641,799,207,774.13$18,268$823.31+$1688429.03MEMHTF
6$61,254,845,187,941$59,448,226,103,092.12$20,408$862.17+$61254845.17MEMHTF
7$2,081,181,684,947,090$2,015,639,000,595,993.00$22,737$900.20+$2081181684.92MEMHTF
8$66,229,598,087,621,200$64,002,733,684,727,816.00$25,266$937.31+$66229598087.60MEMHTF
9$1,974,383,155,320,608,300$1,903,517,485,366,853,600.00$28,008$973.42+$1974383155320.58MEMHTF
10$55,146,348,937,607,240,000$53,033,758,961,414,200,000.00$30,977$1,008.47+$55146348937607.21MEMHTF

EMHTF vs DIVO: Complete Analysis 2026

EMHTFStock

Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada. As of November 10, 2022, Emerald Health Therapeutics, Inc. operates as a subsidiary of Skye Bioscience, Inc.

Full EMHTF Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this EMHTF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMHTF vs SCHDEMHTF vs JEPIEMHTF vs OEMHTF vs KOEMHTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.